To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients
To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients
Not yet recruiting · NCT06589518 · Registry updated 2025-02-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients | Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hepadnaviridae infectious disease, Infections, Male Urogenital Diseases, Urogenital Diseases, hepatitis, hepatitis B virus infection, infectious disease, kidney disorder, kidney failure, liver disorder, urinary system disorder, viral hepatitis, viral infectious disease | Not yet recruiting | Phase 2 | 2025-02-04 | NCT06589518 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jongman Kim | 2 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||